#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	206	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1019	10.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	276	278	ACG	10;11;11	A;C;G	10;11;10	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	C897G	SNP	897	897	C	12	12	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	T898C	SNP	898	898	T	13	13	C	4	C	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	G906T	SNP	906	906	G	21	21	T	8	T,C	7,1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	G908A	SNP	908	908	G	23	23	A	8	A	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	A918T	SNP	918	918	A	33	33	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	A943G	SNP	943	943	A	58	58	G	22	G	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	130	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c30.ctg.2	156	10.0	0	.	n	.	0	G991T	SNP	991	991	G	106	106	T	13	T	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	734	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c4.ctg.2	1494	24.9	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1300	1302	AGC	9;9;10	A;G;C	9;9;10	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	734	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c4.ctg.2	1494	24.9	1	SNP	p	R234F	1	.	.	700	702	TTC	775	777	TTC	39;40;41	T;T;C	39;40;41	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	734	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c4.ctg.2	1494	24.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1075	1077	CGT	46;46;45	C;G;T	46;46;45	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	734	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c4.ctg.2	1494	24.9	0	HET	.	.	.	T999C	.	999	999	T	1074	1074	T	44	T,C	29,14	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	292	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1718	9.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1467	1469	AAA	5;5;5	A;A;A	5;5;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	324	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1651	10.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1207	1209	GAA	7;8;8	G;A;A	7;8;8	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	19	82	H_NS	414	403	99.01	H_NS.l6.c4.ctg.1	593	6.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	366	PmrB_1	1092	1092	99.27	PmrB_1.l15.c17.ctg.1	1285	14.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	186	188	CGT	9;10;10	C;G;T	9;10;10	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	366	PmrB_1	1092	1092	99.27	PmrB_1.l15.c17.ctg.1	1285	14.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1029	1031	GGC	15;15;14	G;G;C	15;15;14	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	531	548	PmrC	1644	1641	99.15	PmrC.l6.c30.ctg.1	1752	15.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	133	135	AGC	4;4;4	A;G;C	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	531	548	PmrC	1644	1641	99.15	PmrC.l6.c30.ctg.1	1752	15.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	535	537	CTA	13;12;11	C;T;A	12;12;11	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	531	548	PmrC	1644	1641	99.15	PmrC.l6.c30.ctg.1	1752	15.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1054	1056	CAA	23;23;24	C;A;A	23;23;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	531	548	PmrC	1644	1641	99.15	PmrC.l6.c30.ctg.1	1752	15.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1153	1155	GGT	21;21;20	G;G;T	21;21;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	531	548	PmrC	1644	1641	99.15	PmrC.l6.c30.ctg.1	1752	15.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1723	1725	GTT	5;5;4	G;T;T	5;5;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	186	PmrE	1167	650	97.38	PmrE.l15.c30.ctg.1	879	8.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	601	603	GAA	7;7;7	G;A;A	7;7;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	186	PmrE	1167	650	97.38	PmrE.l15.c30.ctg.1	879	8.3	0	.	p	.	0	E168trunc	TRUNC	502	502	G	730	730	T	5	T,G	3,2	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	186	PmrE	1167	650	97.38	PmrE.l15.c30.ctg.1	879	8.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	781	783	ACC	3;3;3	A;C;C	3;3;3	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	186	PmrE	1167	114	98.25	PmrE.l15.c30.ctg.2	172	2.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	10	12	ATC	2;2;2	A;T;C	2;2;2	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	186	PmrE	1167	169	97.04	PmrE.l15.c30.ctg.3	169	5.1	0	.	p	.	0	E331G	NONSYN	991	993	GAA	153	155	GGA	1;1;1	G;G;A	1;1;1	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	228	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1182	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	513	610	acrD	3114	1815	99.23	acrD.l15.c4.ctg.1	1815	10.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	732	734	AAG	3;3;4	A;A;G	3;3;4	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	513	610	acrD	3114	1080	98.89	acrD.l15.c4.ctg.2	1080	11.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	100	102	ATC	13;13;13	A;T;C	13;13;13	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	513	610	acrD	3114	165	99.39	acrD.l15.c4.ctg.3	201	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	290	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1382	10.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	225	227	GTC	3;1;2	G;T;C	3;1;2	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	290	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1382	10.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	966	968	TGC	13;13;13	T;G;C	13;13;13	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	215	215	T	9	T	9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	521	523	GAC	7;8;8	G;A;C	7;8;8	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	797	799	TTA	5;5;5	T;T;A	5;5;5	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1874	1876	AAT	19;19;19	A;A;T	19;19;19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1988	1990	AGT	5;6;6	A;G;T	5;6;6	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2387	2389	GTG	14;14;14	G;T;G	14;13;14	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	758	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3240	12.3	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2942	2944	AAG	14;14;14	A;A;G	14;14;14	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	124	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	869	7.0	1	SNP	p	R45C	0	.	.	133	135	CGC	144	146	CGC	8;7;7	C;G;C	8;7;7	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	124	acrS	663	663	98.79	acrS.l15.c30.ctg.1	737	7.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	131	133	TTC	3;3;3	T;T;C	3;3;3	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	124	acrS	663	663	98.79	acrS.l15.c30.ctg.1	737	7.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	395	397	GGG	12;11;11	G;G;G	12;11;11	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	260	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1114	12.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	584	586	CTT	17;17;17	C;T;T	17;17;17	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	696	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3038	12.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2104	2106	GCA	17;17;19	G;C;A	17;17;19	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	696	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3038	12.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2365	2367	ACC	9;9;9	A;C;C	9;9;9	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	696	alaS	2631	2631	98.94	alaS.l6.c4.ctg.1	3038	12.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2674	2676	GCC	8;7;7	G;C;C	8;7;7	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	334	arnA_1	1983	1660	98.49	arnA_1.l6.c4.ctg.1	1660	9.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	146	148	GTT	6;6;7	G;T;T	6;6;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	334	arnA_1	1983	1660	98.49	arnA_1.l6.c4.ctg.1	1660	9.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	296	298	CAC	8;8;8	C;A;C	8;8;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	334	arnA_1	1983	1660	98.49	arnA_1.l6.c4.ctg.1	1660	9.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	581	583	ATG	11;11;11	A;T;G	11;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	334	arnA_1	1983	1660	98.49	arnA_1.l6.c4.ctg.1	1660	9.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1577	1579	CGC	8;8;8	C;G;C	8;8;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	334	arnA_1	1983	104	98.08	arnA_1.l6.c4.ctg.3	104	6.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	5	7	GCT	5;5;6	G;C;T	4;4;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	170	bacA	822	804	98.63	bacA.l6.c4.ctg.1	1002	8.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	859	861	ACC	3;3;3	A;C;C	3;3;3	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	170	bacA	822	804	98.63	bacA.l6.c4.ctg.1	1002	8.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	871	873	TCG	2;1;1	T;C;G	2;1;1	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	531	140	baeR	723	677	97.78	baeR.l15.c4.ctg.1	707	9.5	0	.	p	.	0	S214F	NONSYN	640	642	TCT	667	669	TTT	2;2;2	T;T;T	2;2;2	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	324	baeS	1404	1324	98.79	baeS.l15.c30.ctg.1	1434	11.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1236	1238	AAA	5;6;6	A;A;A	4;6;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	324	baeS	1404	1324	98.79	baeS.l15.c30.ctg.1	1434	11.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1248	1250	GAG	5;4;4	G;A;G	5;3;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	324	baeS	1404	1324	98.79	baeS.l15.c30.ctg.1	1434	11.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1254	1256	CAC	5;5;4	C;A;C	4;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	324	baeS	1404	1324	98.79	baeS.l15.c30.ctg.1	1434	11.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1308	1310	GAG	5;5;5	G;A;G	5;5;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	513	376	cpxA	1374	1240	98.87	cpxA.l15.c4.ctg.1	1480	12.3	0	.	p	.	0	A231T	NONSYN	691	693	GCG	931	933	ACG	10;10;10	A;C;G	10;10;10	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	513	376	cpxA	1374	138	97.83	cpxA.l15.c4.ctg.2	290	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	200	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	726	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	162	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1325	6.6	0	.	p	.	0	T132I	NONSYN	394	396	ACA	575	577	ATA	9;8;8	A;T;A	9;8;8	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	262	emrA	1173	1173	98.38	emrA.l15.c4.ctg.1	1210	10.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	673	675	GTC	16;16;16	G;T;C	16;15;15	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	434	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	1959	11.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	667	340	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1560	11.6	0	.	p	.	0	G209S	NONSYN	625	627	GGC	773	775	AGC	10;10;10	A;G;C	10;10;10	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	667	340	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1560	11.6	0	HET	.	.	.	G697C	.	697	697	G	845	845	G	17	G,C	10,7	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	220	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1136	9.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	582	584	AGG	9;9;9	A;G;G	9;9;9	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	220	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1136	9.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	972	974	GAC	4;4;5	G;A;C	4;4;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	154	emrR	531	531	100.0	emrR.l15.c30.ctg.1	932	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	336	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1927	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	134	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1008	7.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	402	404	CTG	7;8;8	C;T;G	7;7;8	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	660	98.03	evgS.l15.c30.ctg.1	660	7.9	0	.	p	.	0	I499L	NONSYN	1495	1497	ATT	193	195	CTT	7;7;8	C,A;T;T	0,7;7;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	11	13	TCA	3;3;3	T;C;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	140	142	CAG	4;4;4	C;A;G	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	278	280	GTT	8;7;6	G;T;T	8;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	434	436	GAT	1;1;1	G;A;T	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	602	604	AAT	3;3;3	A;A;T	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	626	96.49	evgS.l15.c30.ctg.2	626	5.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	623	625	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	91.82	evgS.l15.c30.ctg.3	269	6.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	38	40	CAT	6;6;5	C;A;T	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	91.82	evgS.l15.c30.ctg.3	269	6.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	92	94	CAT	4;4;4	C;A;T	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	91.82	evgS.l15.c30.ctg.3	269	6.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	110	112	AGA	6;5;5	A;G;A	6;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	91.82	evgS.l15.c30.ctg.3	269	6.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	125	127	AAT	4;4;5	A;A;T	4;4;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	1334	99.1	evgS.l15.c30.ctg.4	1398	10.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	6	8	TCC	4;4;6	T;C;C	4;4;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	1334	99.1	evgS.l15.c30.ctg.4	1398	10.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	171	173	ATT	9;9;9	A;T;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	1334	99.1	evgS.l15.c30.ctg.4	1398	10.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	192	194	GAT	10;10;10	G;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	1334	99.1	evgS.l15.c30.ctg.4	1398	10.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	306	308	GTT	10;10;10	G;T;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	1334	99.1	evgS.l15.c30.ctg.4	1398	10.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	591	593	CAC	11;11;11	C;A;C	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	98.88	evgS.l15.c30.ctg.5	322	11.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	165	167	ATA	4;4;4	A;T;A	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	600	evgS	3594	269	98.88	evgS.l15.c30.ctg.5	322	11.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	177	179	GTA	2;3;3	G;T;A	2;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	206	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1062	10.1	1	SNP	p	P64A	0	.	.	190	192	CCA	330	332	CCA	18;19;18	C;C;A	18;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	206	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1062	10.1	1	SNP	p	P64R	0	.	.	190	192	CCA	330	332	CCA	18;19;18	C;C;A	18;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	206	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1062	10.1	1	SNP	p	P64S	0	.	.	190	192	CCA	330	332	CCA	18;19;18	C;C;A	18;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	206	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1062	10.1	1	SNP	p	P64H	0	.	.	190	192	CCA	330	332	CCA	18;19;18	C;C;A	18;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	206	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1062	10.1	1	SNP	p	P64L	0	.	.	190	192	CCA	330	332	CCA	18;19;18	C;C;A	18;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	136	gadE	528	528	100.0	gadE.l6.c30.ctg.1	867	8.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	0	38	gadW	729	124	97.58	gadW.l15.c4.ctg.1	125	6.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	0	38	gadW	729	116	96.55	gadW.l15.c4.ctg.3	116	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	148	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1013	7.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	315	317	TTA	12;12;11	T;T;A	12;12;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	148	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1013	7.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	393	395	ATT	4;4;4	A;T;T	4;4;4	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	148	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1013	7.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	894	896	GGA	4;5;5	G;G;A	4;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	148	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1013	7.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	900	902	CCG	5;5;5	C;C;G	5;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2261	2263	GAA	16;15;16	G;A;A	16;15;16	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	S83L	0	.	.	247	249	TCG	476	478	TCG	10;10;10	T;C;G	10;10;10	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	S83W	0	.	.	247	249	TCG	476	478	TCG	10;10;10	T;C;G	10;10;10	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	S83I	0	.	.	247	249	TCG	476	478	TCG	10;10;10	T;C;G	10;10;10	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	D87N	0	.	.	259	261	GAC	488	490	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	D87H	0	.	.	259	261	GAC	488	490	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	D87V	0	.	.	259	261	GAC	488	490	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	488	490	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	602	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3039	10.6	1	SNP	p	D87G	0	.	.	259	261	GAC	488	490	GAC	9;9;9	G;A;C	9;9;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	0	.	p	.	0	E390K	NONSYN	1168	1170	GAA	1217	1219	AAA	7;9;9	A,G;A;A	0,2;9;9	.	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136G	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136C	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136E	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136S	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136L	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136H	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	582	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2603	11.7	1	SNP	p	R136I	0	.	.	406	408	CGC	455	457	CGC	10;11;12	C;G;C	10;11;12	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	108	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	767	7.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	287	289	CCG	9;10;10	C;C;G	9;10;10	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	108	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	767	7.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	440	442	GCC	4;4;4	G;C;C	4;4;4	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	244	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1300	9.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	153	155	TCA	7;8;8	T;C;A	7;8;7	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	92	marA	384	384	99.74	marA.l15.c30.ctg.1	691	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	V45E	0	.	.	133	135	GTG	324	326	GTG	7;7;7	G;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	I49S	0	.	.	145	147	ATC	336	338	ATC	6;6;6	A;T;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	A70T	0	.	.	208	210	GCA	399	401	GCA	6;6;5	G;C;A	6;6;5	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	R73S	0	.	.	217	219	CGT	408	410	CGT	5;5;5	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	R73C	0	.	.	217	219	CGT	408	410	CGT	5;5;5	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	R77L	0	.	.	229	231	CGC	420	422	CGC	4;4;3	C;G;C	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	R77C	0	.	.	229	231	CGC	420	422	CGC	4;4;3	C;G;C	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	16	46	marR	435	257	98.44	marR.l15.c30.ctg.1	448	4.6	1	SNP	p	L78M	0	.	.	232	234	CTG	423	425	CTG	3;3;3	C;T;G	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	89	91	ATC	5;5;5	A;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	107	109	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	110	112	GTG	3;3;3	G;T;G	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	137	139	GAT	4;4;4	G;A;T	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	158	160	ACC	3;3;3	A;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	185	187	TTA	3;3;3	T;T;A	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	326	328	CAG	12;12;12	C;A;G	12;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	365	367	GCC	7;6;6	G;C;C	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	470	472	GCG	6;7;7	G;C;G	6;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	674	676	GTT	11;11;11	G;T;T	10;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	186	mdfA	1233	1139	96.93	mdfA.l15.c30.ctg.2	1137	7.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	836	836	C	7	C	7	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	430	96.51	mdtA.l6.c4.ctg.1	603	6.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	213	213	G	13	G	13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	430	96.51	mdtA.l6.c4.ctg.1	603	6.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	270	272	CAG	4;5;5	C;A;G	4;5;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	430	96.51	mdtA.l6.c4.ctg.1	603	6.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	420	422	ATC	7;7;7	A;T;C	7;7;7	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	430	96.51	mdtA.l6.c4.ctg.1	603	6.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	468	470	ATG	2;2;2	A;T;G	2;2;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	430	96.51	mdtA.l6.c4.ctg.1	603	6.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	561	563	ACC	5;4;4	A;C;C	5;4;4	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	517	204	mdtA	1248	857	97.78	mdtA.l6.c4.ctg.2	928	7.0	0	.	p	.	0	D137N	NONSYN	409	411	GAT	18	20	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1891	1893	ACC	14;12;11	A;C;C	14;12;11	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2284	2286	CAA	4;5;4	C;A;A	3;5;3	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2452	2454	ATT	13;13;12	A;T;T	13;13;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2536	2538	GTT	9;9;9	G;T;T	9;9;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2644	2646	GAG	10;10;9	G;A;G	10;10;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2872	2874	ATG	8;8;8	A;T;G	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	752	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3394	11.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3007	3009	GAT	12;11;11	G;A;T	12;9;11	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	690	mdtC	3078	2677	98.84	mdtC.l15.c4.ctg.1	2677	12.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	376	378	ATC	12;12;11	A;T;C	12;12;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	690	mdtC	3078	190	97.89	mdtC.l15.c4.ctg.2	190	7.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	75	77	ATG	12;12;13	A;T;G	12;12;13	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	690	mdtC	3078	151	97.35	mdtC.l15.c4.ctg.4	162	6.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	11	13	CAC	2;2;2	C;A;C	2;2;2	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	296	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1605	9.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	182	184	GAA	6;5;5	G;A;A	6;5;5	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	296	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1605	9.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	851	853	GCG	15;15;15	G;C;G	15;15;15	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	296	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1605	9.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1193	1195	ATC	7;7;7	A;T;C	7;7;7	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	296	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1605	9.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1496	1498	TTT	9;9;10	T;T;T	9;9;10	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	539	388	mdtE	1158	1158	99.22	mdtE.l15.c30.ctg.1	1554	13.3	0	.	p	.	0	I231V	NONSYN	691	693	ATC	883	885	GTC	22;21;21	G;T;C	22;21;21	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	756	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3543	11.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1092	1094	ACC	10;10;11	A;C,A;C	10;9,1;11	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	756	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3543	11.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2334	2336	GAC	17;17;17	G;A;C	17;17;17	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	248	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1471	7.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	650	652	ATC	7;7;8	A;T;C	7;7;8	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	248	mdtG	1227	175	99.43	mdtG.l15.c4.ctg.2	348	5.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	6	8	GGA	3;3;3	G;G;A	3;3;3	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	190	mdtH	1209	839	98.45	mdtH.l6.c4.ctg.1	844	9.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	202	204	TGT	8;8;8	T;G;T	8;8;8	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	190	mdtH	1209	839	98.45	mdtH.l6.c4.ctg.1	844	9.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	772	774	TTG	9;9;10	T;T;G	9;9;10	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	190	mdtH	1209	107	99.07	mdtH.l6.c4.ctg.2	107	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	190	mdtH	1209	157	95.54	mdtH.l6.c4.ctg.3	168	4.4	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	23	25	CAG	5;5;5	C;A;G	4;4;4	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	190	mdtH	1209	157	95.54	mdtH.l6.c4.ctg.3	168	4.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	128	130	ACG	3;3;3	A;C;G	3;3;3	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	270	mdtL	1176	1176	98.47	mdtL.l15.c30.ctg.1	1516	9.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	644	646	TCC	7;7;7	T;C;C	7;7;7	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	346	mdtN	1032	1032	98.16	mdtN.l15.c4.ctg.1	1338	12.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	618	620	ATT	13;13;13	A;T;T	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	V11M	NONSYN	31	33	GTG	178	180	ATG	10;11;12	A;T;G	10;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	T33I	NONSYN	97	99	ACC	244	246	ATC	15;16;16	A;T;C	15;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	C116R	NONSYN	346	348	TGC	493	495	CGC	8;8;9	C;G;C	8;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	N238S	NONSYN	712	714	AAC	859	861	AGC	20;20;18	A;G;C	20;20;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1060	1062	GTG	12;11;11	G;T;G	12;10;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1123	1125	AAC	10;10;10	A;A;C	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1168	1170	GTC	11;11;11	G;T;C	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1198	1200	ATA	19;19;19	A;T;A	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1306	1308	TCT	10;10;10	T;C;T	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1693	1695	GCG	14;14;14	G;C;G	14;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	644	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2379	14.3	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1906	1908	ATC	13;14;14	A;T;C	13;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	518	520	GCG	9;10;10	G;C;G	9;9;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	692	694	ACC	19;18;18	A;C;C	19;18;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	764	766	CGC	18;16;15	C;G;C	18;16;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	881	883	GCT	13;15;15	G;C;T	12;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	965	967	AAA	7;7;7	A;A;A	7;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	983	985	CGA	10;11;11	C;G;A	9;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1148	1150	GCC	9;9;9	G;C;C	9;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1160	1162	GAT	11;11;11	G;A;T	11;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	438	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1752	13.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1577	1579	GCT	6;5;5	G;C;T	6;4;5	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	634	mfd	3447	3121	99.04	mfd.l6.c4.ctg.1	3280	9.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1468	1470	AAG	5;5;5	A;A;G	5;5;4	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	634	mfd	3447	3121	99.04	mfd.l6.c4.ctg.1	3280	9.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2545	2547	CTG	9;9;9	C;T;G	9;9;9	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	634	mfd	3447	3121	99.04	mfd.l6.c4.ctg.1	3280	9.2	0	.	p	.	0	E1038trunc	TRUNC	3112	3112	G	3271	3271	T	2	T,G	1,1	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	634	mfd	3447	337	100.0	mfd.l6.c4.ctg.2	540	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	56	mgrB	144	142	100.0	mgrB.l15.c30.ctg.1	156	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	478	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	1884	13.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	928	930	AAC	14;13;14	A;A;C	14;13;14	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	478	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	1884	13.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1474	1476	ATA	15;16;15	A;T;A	15;16;15	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1584	11.1	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1195	1197	GTG	10;11;11	G;T;G	10;11;11	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1584	11.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1273	1275	GAT	13;13;13	G;A;T	12;13;12	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	330	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1584	11.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1276	1278	CTG	13;13;13	C;T;G	13;12;13	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	134	136	TGT	3;5;4	T;G;T	3;4;3	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	404	406	ACC	6;6;6	A;C;C	6;6;6	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	614	616	GAC	5;5;5	G;A;C	5;4;5	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	1	SNP	p	R15C	0	.	.	43	45	CGC	98	100	CGC	11;12;12	C;G;C	11;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	1	SNP	p	S33R	0	.	.	97	99	AGC	152	154	AGC	5;4;4	A;G;C	5;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	1	SNP	p	G131D	0	.	.	391	393	GGC	446	448	GGC	7;7;7	G;G;C	7;7;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	1	SNP	p	R203L	0	.	.	607	609	CGT	662	664	CGT	7;8;8	C;G;T	7;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	118	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	820	6.7	1	SNP	p	R203C	0	.	.	607	609	CGT	662	664	CGT	7;8;8	C;G;T	7;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	340	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1450	12.6	1	SNP	p	G141D	0	.	.	421	423	GGT	579	581	GGT	11;11;13	G;G;T	11;11;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	340	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1450	12.6	1	SNP	p	G141E	0	.	.	421	423	GGT	579	581	GGT	11;11;13	G;G;T	11;11;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	340	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1450	12.6	1	SNP	p	R154D	0	.	.	460	462	CGT	618	620	CGT	20;20;21	C;G;T	20;20;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	340	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1450	12.6	1	SNP	p	R154A	0	.	.	460	462	CGT	618	620	CGT	20;20;21	C;G;T	20;20;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	636	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2590	13.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1806	1808	TCG	5;8;8	T;C;G	5;8;8	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	636	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2590	13.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2421	2423	AAC	17;17;17	A;A;C	17;17;17	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	636	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2590	13.1	1	SNP	p	A85T	0	.	.	253	255	GCG	435	437	GCG	10;10;10	G;C;G	10;10;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	636	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2590	13.1	1	SNP	p	D111H	0	.	.	331	333	GAT	513	515	GAT	13;12;13	G;A;T	13;12;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	636	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2590	13.1	1	SNP	p	S129P	0	.	.	385	387	TCC	567	569	TCC	14;15;14	T;C;C	14;15;14	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	257	436	parE_1	1893	1604	97.57	parE_1.l6.c30.ctg.1	1770	10.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1137	1139	GAT	9;9;9	G;A;T	9;9;8	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	257	436	parE_1	1893	208	98.54	parE_1.l6.c30.ctg.2	368	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	368	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1807	10.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1260	1262	GAT	14;13;13	G;A;T	14;13;13	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	0	.	p	.	0	D912N	NONSYN	2734	2736	GAC	2917	2919	AAC	1;1;1	A;A;C	1;1;1	.	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	V146F	0	.	.	436	438	GTT	619	621	GTT	13;13;13	G;T;T	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1720	1722	CAG	14;14;13	C;A;G	14;14;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1720	1722	CAG	14;14;13	C;A;G	14;14;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1759	1761	CAC	8;7;8	C;A;C	7;7;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1768	1770	CGT	7;7;7	C;G;T	7;6;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1768	1770	CGT	7;7;7	C;G;T	7;6;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1774	1776	TCC	7;7;7	T;C;C	7;7;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1780	1782	CTC	6;5;5	C;T;C	5;5;5	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1870	1872	ACC	10;10;10	A;C;C	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1873	1875	CCT	10;10;10	C;C;T	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	2740	98.94	rpoB.l6.c4.ctg.1	2923	13.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2242	2244	CGT	21;21;20	C;G;T	21;21;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	513	1106	rpoB	4029	1289	99.15	rpoB.l6.c4.ctg.2	1368	13.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	.	n	.	0	A226G	SNP	226	226	A	347	347	G	104	G	103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	A794G	0	.	.	794	794	A	915	915	A	96	A	92	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	A794T	0	.	.	794	794	A	915	915	A	96	A	92	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	G926T	0	.	.	926	926	G	1047	1047	G	96	G	96	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	G926A	0	.	.	926	926	G	1047	1047	G	96	G	96	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	G926C	0	.	.	926	926	G	1047	1047	G	96	G	96	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	1640	1640	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	1640	1640	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	1640	1640	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	G1002A	.	1002	1002	G	1123	1123	G	101	G,A	73,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	G1006C	.	1006	1006	G	1127	1127	G	103	G,C	77,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	A79G	.	79	79	A	200	200	A	88	A,G	66,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	C719T	.	719	719	C	840	840	C	88	C,T	55,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	C1038T,G	.	1038	1038	C	1159	1159	C	106	C,T,G	78,26,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	T1010C	.	1010	1010	T	1131	1131	T	106	T,C	78,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	C183T	.	183	183	C	304	304	C	85	C,T	68,17	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	G474A,T	.	474	474	G	595	595	G	96	G,A,T	76,18,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	T90C	.	90	90	T	211	211	T	93	T,C	71,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	A250T	.	250	250	A	371	371	A	85	A,T	64,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3114	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	2026	80.2	0	HET	.	.	.	A253T	.	253	253	A	374	374	A	81	A,T	62,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	222	soxR	465	465	100.0	soxR.l15.c4.ctg.1	791	14.7	1	SNP	p	R20H	0	.	.	58	60	CGC	263	265	CGC	26;26;26	C;G;C	26;26;26	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	222	soxR	465	465	100.0	soxR.l15.c4.ctg.1	791	14.7	1	SNP	p	G121D	0	.	.	361	363	GGT	566	568	GGT	17;17;17	G;G;T	17;17;17	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	164	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	726	12.0	1	SNP	p	A12S	0	.	.	34	36	GCA	230	232	GCA	24;24;25	G;C;A	24;23;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	478	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1597	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	374	tetR	651	651	100.0	tetR.l15.c17.ctg.1	1072	18.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	378	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	1873	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
